Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b Study of Relamorelin (RM-131) in Diabetic Gastroparesis with Vomiting
2014-005623-27Phase 2Completed
- Sponsor
- Rhythm Pharmaceuticals
- Start
- Feb 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic gastroparesis comparing Relamorelin with Placebo (2 arms). Started Feb 2015; status: completed.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on 2014-005623-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005623-27.